China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

China Resources Double-Crane Pharmaceutical Co.,Ltd. Statistics

Total Valuation

China Resources Double-Crane Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 22.67 billion. The enterprise value is 21.37 billion.

Market Cap	22.67B
Enterprise Value	21.37B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Nov 8, 2024

Share Statistics

China Resources Double-Crane Pharmaceutical Co.,Ltd. has 1.03 billion shares outstanding. The number of shares has decreased by -0.71% in one year.

Current Share Class	n/a
Shares Outstanding	1.03B
Shares Change (YoY)	-0.71%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	11.59%
Float	399.81M

Valuation Ratios

The trailing PE ratio is 16.83 and the forward PE ratio is 12.90.

PE Ratio	16.83
Forward PE	12.90
PS Ratio	2.20
PB Ratio	2.23
P/TBV Ratio	n/a
P/FCF Ratio	20.96
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.77, with an EV/FCF ratio of 19.76.

EV / Earnings	15.86
EV / Sales	2.07
EV / EBITDA	9.77
EV / EBIT	14.34
EV / FCF	19.76

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.07.

Current Ratio	1.59
Quick Ratio	1.19
Debt / Equity	0.07
Debt / EBITDA	0.34
Debt / FCF	0.66
Interest Coverage	120.65

Financial Efficiency

Return on equity (ROE) is 12.07% and return on invested capital (ROIC) is 7.67%.

Return on Equity (ROE)	12.07%
Return on Assets (ROA)	5.63%
Return on Capital (ROIC)	7.67%
Revenue Per Employee	841,305
Profits Per Employee	109,858
Employee Count	12,269
Asset Turnover	0.65
Inventory Turnover	2.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.85% in the last 52 weeks. The beta is 0.14, so China Resources Double-Crane Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+19.85%
50-Day Moving Average	22.11
200-Day Moving Average	20.55
Relative Strength Index (RSI)	51.08
Average Volume (20 Days)	21,456,672

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, China Resources Double-Crane Pharmaceutical Co.,Ltd. had revenue of CNY 10.32 billion and earned 1.35 billion in profits. Earnings per share was 1.31.

Revenue	10.32B
Gross Profit	5.79B
Operating Income	1.42B
Pretax Income	1.54B
Net Income	1.35B
EBITDA	2.10B
EBIT	1.42B
Earnings Per Share (EPS)	1.31

Balance Sheet

The company has 2.71 billion in cash and 711.52 million in debt, giving a net cash position of 1.99 billion or 1.94 per share.

Cash & Cash Equivalents	2.71B
Total Debt	711.52M
Net Cash	1.99B
Net Cash Per Share	1.94
Equity (Book Value)	10.89B
Book Value Per Share	9.89
Working Capital	2.72B

Cash Flow

In the last 12 months, operating cash flow was 1.84 billion and capital expenditures -757.67 million, giving a free cash flow of 1.08 billion.

Operating Cash Flow	1.84B
Capital Expenditures	-757.67M
Free Cash Flow	1.08B
FCF Per Share	1.05

Margins

Gross margin is 56.06%, with operating and profit margins of 13.79% and 13.06%.

Gross Margin	56.06%
Operating Margin	13.79%
Pretax Margin	14.95%
Profit Margin	13.06%
EBITDA Margin	20.30%
EBIT Margin	13.79%
FCF Margin	10.48%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.90%.

Dividend Per Share	0.20
Dividend Yield	0.90%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	83.33%
Buyback Yield	0.71%
Shareholder Yield	1.61%
Earnings Yield	5.94%
FCF Yield	4.77%

Stock Splits

The last stock split was on August 16, 2018. It was a forward split with a ratio of 1.2.

Last Split Date	Aug 16, 2018
Split Type	Forward
Split Ratio	1.2

Scores

China Resources Double-Crane Pharmaceutical Co.,Ltd. has an Altman Z-Score of 3.98.

Altman Z-Score	3.98
Piotroski F-Score	n/a